NextCure, Inc. (NXTC)
NextCure has a market cap or net worth of $213.44 million. The enterprise value is -$35.15 million.
NextCure has 27.61 million shares outstanding. The number of shares has increased by 0.34% in one year.
|Shares Change (YoY)||+0.34%|
|Shares Change (QoQ)||+0.05%|
|Owned by Insiders (%)||13.45%|
|Owned by Institutions (%)||63.73%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 30.20, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||-0.04|
|Debt / FCF||-0.05|
|Return on Equity (ROE)||-23.20%|
|Return on Assets (ROA)||-22.30%|
|Return on Capital (ROIC)||-25.60%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$737,200|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -35.80% in the last 52 weeks. The beta is -0.37, so NextCure's price volatility has been lower than the market average.
|52-Week Price Change||-35.80%|
|50-Day Moving Average||7.61|
|200-Day Moving Average||7.85|
|Average Volume (30 Days)||302,596|
Short Selling Information
|Short % of Shares Out||2.84%|
|Short % of Float||4.48%|
|Short Ratio (days to cover)||5.51|
|Earnings Per Share (EPS)||-$2.41|
The company has $251.23 million in cash and $2.64 million in debt, giving a net cash position of $248.59 million or $9.00 per share.
|Cash & Cash Equivalents||251.23M|
|Net Cash Per Share||$9.00|
|Book Value Per Share||9.55|
In the last 12 months, operating cash flow was -$53.08 million and capital expenditures -$3.83 million, giving a free cash flow of -$56.92 million.
|Operating Cash Flow||-53.08M|
|Free Cash Flow||-56.92M|
|FCF Per Share||-$2.06|
Dividends & Yields
NextCure does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|